自己免疫性肝疾患における腸肝軸の微生物調節
1State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, China.
Seminars in liver disease
|August 27, 2025
まとめ
腸内微生物群は,腸肝軸を通して免疫反応に影響を与えることで,自己免疫性肝疾患 (AILD) に重要な役割を果たします. 腸内細菌とその代謝産物を調節することで,AILDに対する潜在的な治療戦略が提供されます.
科学分野:
- 胃腸科と肝臓科
- 免疫学
- 微生物学
背景:
- 自己免疫性肝疾患 (AILD) は慢性炎症性疾患である.
- 遺伝的,環境的,免疫的要因が AILD に寄与する.
- 腸肝軸経由で免疫調節における腸内微生物群の役割はますます認識されています.
研究 の 目的:
- 腸内微生物とAILDの相互作用をレビューする.
- 腸の機能不全と肝炎を 関連付けるメカニズムを探る
- 腸内微生物群を標的とした 治療戦略について議論する
主な方法:
- 腸内微生物群とAILDに関する研究の文献レビュー
- バクテリアの転移とバリア破壊を含むメカニズムの分析
- 免疫経路に対する微生物代謝物の影響の検討
主要な成果:
- バクテリアや真菌のコミュニティにおけるディスバイオシスは,免疫機能の調節不全と肝炎に関連しています.
- SCFA,胆酸,LPSのような微生物代謝物は肝臓の免疫耐性を影響する.
- 腸肝軸の変異はAILDの病原性の中心です.
結論:
- 腸内微生物群をプロバイオティクスやFMTでターゲットにすることで AILDの治療の可能性が示されています
- 臨床翻訳は,個体間の変動性と軸の複雑さによって制限されます.
- AILDの管理には腸内微生を活用した精密医療戦略が必要である.
関連する概念動画
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Autoimmune Disorders
667
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
667
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
Inflammatory Response
7.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.0K


